HealthEquity Gestion
Gestion contrôle des critères 3/4
Le PDG HealthEquity est Jon Kessler, nommé en Feb2014, a un mandat de 10.75 ans. La rémunération annuelle totale est $ 13.45M, composée du salaire de 5.2% et des bonus 94.8%, y compris les actions et options de la société. détient directement 0.35% des actions de la société, d'une valeur de $ 30.26M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3 ans et 7.7 ans.
Informations clés
Jon Kessler
Directeur général
US$13.4m
Rémunération totale
| Pourcentage du salaire du PDG | 5.2% |
| Durée du mandat du directeur général | 10.8yrs |
| Propriété du PDG | 0.4% |
| Durée moyenne d'occupation des postes de direction | 3yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.7yrs |
Mises à jour récentes de la gestion
Recent updates
We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt
Oct 31
Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult
Aug 30HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Jul 13We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation
Jun 21Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jun 07HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?
May 03Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues
Apr 11HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects
Dec 28Is HealthEquity (NASDAQ:HQY) A Risky Investment?
Nov 17HealthEquity, Inc.'s (NASDAQ:HQY) Intrinsic Value Is Potentially 51% Above Its Share Price
Oct 26Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Jul 27HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 07Does HealthEquity (NASDAQ:HQY) Have A Healthy Balance Sheet?
Apr 18Estimating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Mar 14Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?
Dec 24Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Dec 02Is HealthEquity, Inc. (NASDAQ:HQY) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 11These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
Sep 08HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M
Sep 06HealthEquity: Asymmetry In Valuation Continues To Widen
Aug 25HealthEquity COO steps down, CEO to assume his responsibilities
Aug 02Is Now An Opportune Moment To Examine HealthEquity, Inc. (NASDAQ:HQY)?
Jul 27Calculating The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)
Jul 06These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Extensively
May 24Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | US$106m |
| Apr 30 2024 | n/a | n/a | US$80m |
| Jan 31 2024 | US$13m | US$700k | US$56m |
| Oct 31 2023 | n/a | n/a | US$29m |
| Jul 31 2023 | n/a | n/a | US$13m |
| Apr 30 2023 | n/a | n/a | -US$8m |
| Jan 31 2023 | US$13m | US$700k | -US$26m |
| Oct 31 2022 | n/a | n/a | -US$59m |
| Jul 31 2022 | n/a | n/a | -US$62m |
| Apr 30 2022 | n/a | n/a | -US$55m |
| Jan 31 2022 | US$10m | US$700k | -US$44m |
| Oct 31 2021 | n/a | n/a | -US$6m |
| Jul 31 2021 | n/a | n/a | US$723k |
| Apr 30 2021 | n/a | n/a | US$4m |
| Jan 31 2021 | US$9m | US$667k | US$9m |
| Oct 31 2020 | n/a | n/a | US$3m |
| Jul 31 2020 | n/a | n/a | -US$20m |
| Apr 30 2020 | n/a | n/a | -US$332k |
| Jan 31 2020 | US$5m | US$500k | US$40m |
| Oct 31 2019 | n/a | n/a | US$53m |
| Jul 31 2019 | n/a | n/a | US$90m |
| Apr 30 2019 | n/a | n/a | US$93m |
| Jan 31 2019 | US$5m | US$483k | US$74m |
| Oct 31 2018 | n/a | n/a | US$67m |
| Jul 31 2018 | n/a | n/a | US$61m |
| Apr 30 2018 | n/a | n/a | US$56m |
| Jan 31 2018 | US$4m | US$400k | US$47m |
Rémunération vs marché: La rémunération totale de Jon ($USD 13.45M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 7.91M ).
Rémunération et revenus: La rémunération de Jon a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Jon Kessler (56 yo)
10.8yrs
Titularisation
US$13,448,018
Compensation
Mr. Jon Kessler is a Member of the Board of Managers at HealthEquity Advisors, LLC. He has been the Chief Executive Officer and President of HealthEquity, Inc. since February 2014. Mr. Kessler founded Wage...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 10.8yrs | US$13.45m | 0.35% $ 30.3m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 81.1m | |
| CFO & Executive VP | 1.2yrs | US$5.23m | 0.0086% $ 745.1k | |
| Executive VP & CTO | 2.7yrs | US$4.81m | 0.0033% $ 283.5k | |
| Executive VP | 8.2yrs | US$2.64m | 0.044% $ 3.8m | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Executive Vice President of Sales & Relationship Management | 3.3yrs | pas de données | pas de données | |
| Executive Vice President of Corporate Development & Strategy | 7.6yrs | pas de données | pas de données | |
| Executive VP & Chief Marketing Officer | 2.8yrs | pas de données | pas de données | |
| Executive VP & Chief People Officer | 1.6yrs | pas de données | pas de données | |
| Senior VP & Head of Product | 2yrs | pas de données | pas de données | |
| Executive VP & Chief Security Officer | no data | pas de données | pas de données |
3.0yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Gestion expérimentée: L'équipe de direction de HQY est considérée comme expérimentée (ancienneté moyenne 3 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | 15.7yrs | US$13.45m | 0.35% $ 30.3m | |
| Founder & Vice Chairman | 22yrs | US$3.04m | 0.94% $ 81.1m | |
| Independent Director | 8.2yrs | US$297.50k | 0.062% $ 5.4m | |
| Independent Non-Executive Chairman | 9.2yrs | US$362.50k | 0.065% $ 5.7m | |
| Independent Director | 2.2yrs | US$272.50k | 0.0050% $ 434.8k | |
| Independent Director | 10.3yrs | US$290.00k | 0.037% $ 3.2m | |
| Independent Director | 3.9yrs | US$280.00k | 0.035% $ 3.0m | |
| Independent Director | 7.3yrs | US$278.87k | 0.017% $ 1.5m | |
| Independent Director | 6.6yrs | US$275.00k | 0.012% $ 1.0m | |
| Independent Director | 2.5yrs | US$272.50k | 0.0096% $ 831.5k |
7.7yrs
Durée moyenne de l'emploi
62.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de HQY sont considérés comme expérimentés (ancienneté moyenne 7.7 ans).